• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: December 2018

Finance

Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

December 24, 2018 Microbiome Times

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, announced that it has raised $27 million in a Series C financing with […]

Editor's Choice

EMA Rules On Omega-3 Medicinal Products – Useful Parallels for the Pharmabiotics Industry

December 21, 2018 Dr. Magali Cordaillat-Simmons (PhD)

On 13 December 2018, the European Medicines Agency (EMA) released the following statement: “Omega-3 fatty acid medicines are no longer considered as effective in preventing heart disease.” As several communications have been published by multiple […]

Pharma & Human Health

BMS and Boston Medical Center Announce Research Collaboration to Investigate Markers of Immuno-Oncology Response and Resistance

December 20, 2018 Microbiome Times

Bristol-Myers Squibb Company (NYSE:BMY), and Boston Medical Center, a private, not-for-profit, academic medical center, today announced a multi-year joint research study to identify and analyze potential sensitivity and resistance markers in patients treated with standard-of-care […]

Pharma & Human Health

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

December 14, 2018 Microbiome Times

BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has entered into a collaboration with Janssen Research & Development, LLC to utilize BiomX’s XMarker microbiome-based biomarker discovery platform. The XMarker platform […]

Pharma & Human Health

DuPont Nutrition & Health Helps to Reduce Health Risks for Overweight Consumers

December 13, 2018 Microbiome Times

DuPont Nutrition & Health has released new findings from a clinical study of a synbiotic dietary supplement that gives hope to overweight consumers at risk of health complications. Combining the benefits of a proven probiotic […]

Pharma & Human Health

BIOASTER, Bio-Rad and Genetic Analysis Collaborate to Develop Novel Microbiome-Based Diagnostics for Metabolic Disorders

December 12, 2018 Microbiome Times

BIOASTER, the French Technology Research Institute for Microbiology and Infectious Diseases, announced the initiation of a collaborative program with BIOASTER, Bio- Rad Laboratories, Inc. and Genetic Analysis aimed at evaluating microbial dysbiosis signatures in the […]

Finance

BMS and Vedanta Announce Clinical Collaboration to Evaluate OPDIVO and VE800 in Patients with Advanced or Metastatic Cancers

December 10, 2018 Microbiome Times

Bristol-Myers Squibb Company (NYSE:BMY) and Vedanta Biosciences  announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s programmed death-1 (PD-1) immune checkpoint inhibitor Opdivo in combination with Vedanta Biosciences’ VE800, a rationally-defined human bacterial consortium, in patients […]

Finance

Lallemand Health Solutions Invests to Double Probiotic Production Capacity.

December 10, 2018 Microbiome Times

In order to face growing market demand for quality probiotic food supplements, Lallemand Health Solutions is investing in a brand new bacterial production plant in Mirabel, Canada. Using state-of-the-art equipment and production process, the new […]

Pharma & Human Health

Danone North America Announces 2018-2019 Gut Microbiome, Yogurt and Probiotics Fellowship Grant

December 9, 2018 Microbiome Times

Danone North America announces it is awarding two graduate students $25,000 each for the 7th year in a row. As the name indicates, the grant is designed for graduate students to study the role of […]

Pharma & Human Health

MaaT Pharma Presents Positive Phase 1b/2a Study Results in Acute Myeloid Leukemia Patients

December 3, 2018 Microbiome Times

MaaT Pharma announced today the results from its ODYSSEE (NCT02928523) Phase 1b/2a clinical trial demonstrating that the Company’s proprietary MaaT Microbiome Restoration Biotherapeutic (MMRB) therapeutic is able to restore a functional microbiome in acute myeloid […]

Pharma & Human Health

Changed Microbiome After Caesarean Birth Impacts Baby’s Immune System, Research by LCSB Finds

December 1, 2018 Microbiome Times

Together with colleagues from Sweden and Luxembourg, scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have observed that, during a natural vaginal birth, specific bacteria from the mother’s gut […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter